| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/17/2013 | US8536313 Monoclonal antibody having neutralizing activity against MMP13 |
| 09/17/2013 | US8536311 Inhibitor protein of the wnt signal pathway |
| 09/17/2013 | US8536145 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 09/17/2013 | US8536137 Methods for treating nucleoside-induced pain |
| 09/17/2013 | US8536136 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/17/2013 | US8535942 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
| 09/17/2013 | US8535940 Cell growth |
| 09/17/2013 | US8535899 Assay for identifying a modulator of HIF hydroxylase |
| 09/17/2013 | US8535690 Tumor specific animal proteins |
| 09/17/2013 | US8535689 Identification of bacterial autoinducer and use in treating bacterial pathogenicity |
| 09/17/2013 | US8535688 Vaccine |
| 09/17/2013 | US8535687 Smallpox DNA vaccine and the antigens therein that elicit an immune response |
| 09/17/2013 | US8535686 Recombinant HCV E2 glycoprotein |
| 09/17/2013 | US8535685 H3 equine influenza A virus |
| 09/17/2013 | US8535684 Methods of inhibiting HIV infectivity |
| 09/17/2013 | US8535683 Intranasal or inhalational administration of virosomes |
| 09/17/2013 | US8535682 Recombinant vaccine against West Nile Virus |
| 09/17/2013 | US8535681 Sustained drug delivery system |
| 09/17/2013 | US8535680 Anti-LPS factor from Parietaria judaica and methods of use thereof |
| 09/17/2013 | US8535678 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/17/2013 | US8535677 Antibody drug conjugate treatment of colorectal cancer |
| 09/17/2013 | US8535676 Antibody therapy |
| 09/17/2013 | US8535675 Compositions and methods for the diagnosis and treatment of tumor |
| 09/17/2013 | US8535674 Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody |
| 09/17/2013 | US8535673 A humanized antibody that specifically binds an epitope contained within positions 13-28 of A beta; used for treating Alzheimer's disease in both asymptomatic patients and those currently showing symptoms of disease. |
| 09/17/2013 | US8535672 Superantigen binding site wherein T-cell costimulatory pathway is one of CD28/B7 T cell costimulatory pathway, CD40 ligand/CD40, CD2/CD58 and LFA-1 (CD18)/ICAM-1 (CD54) costimulatory pathway; toxic shock syndrome caused by a pyrogenic exotoxin; anticarcinogenic and antiproliferative agents |
| 09/17/2013 | US8535671 Methods of reducing CRP and/or increasing serum albumin in patients in need using IL-6 antibodies of defined epitopic specificity |
| 09/17/2013 | US8535670 Method of treating colorectal cancer tumor |
| 09/17/2013 | US8535669 Methods of treating lupus by administering humanized anti-interleukin 3 receptor alpha chain antibodies |
| 09/17/2013 | US8535668 Chimeric anti-ricin antibody |
| 09/17/2013 | US8535667 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 09/17/2013 | US8535666 Antibody (11C7) anti Nogo-A and its pharmaceutical use |
| 09/17/2013 | US8535665 Process for identification of molecular mimicry and the uses thereof |
| 09/17/2013 | US8535664 Method of treating a pathological syndrome and a pharmaceutical agent |
| 09/17/2013 | US8535658 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 09/17/2013 | CA2631894C Novel trans-adjuvant system |
| 09/17/2013 | CA2606081C Combination of the application of antibodies for immunostimulation together with glucocorticoids |
| 09/17/2013 | CA2563887C Mite allergen zen 1 |
| 09/17/2013 | CA2546794C Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 09/17/2013 | CA2532394C Rg1 antibodies and uses thereof |
| 09/17/2013 | CA2515890C Novel insertion sites in pox vectors |
| 09/17/2013 | CA2482946C Multi plasmid system for the production of influenza virus |
| 09/17/2013 | CA2348382C Chimeric parvovirus vectors and methods of making and administering the same |
| 09/17/2013 | CA2347067C Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer |
| 09/12/2013 | WO2013134768A1 Compositions and methods for treating cancer |
| 09/12/2013 | WO2013134656A1 Induction of th17 immune response |
| 09/12/2013 | WO2013134649A1 Biomarkers for cancer stem cells and related methods of use |
| 09/12/2013 | WO2013134626A1 Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist |
| 09/12/2013 | WO2013134516A1 Methods of treatment with angiopoietin-2 antibodies |
| 09/12/2013 | WO2013134414A1 Bispecific antibodies with an fgf2 binding domain |
| 09/12/2013 | WO2013134365A1 TGF-β1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF |
| 09/12/2013 | WO2013134273A1 Methods for modulation of phosphorus and fgf23 |
| 09/12/2013 | WO2013134225A1 Multivalent vaccine protection from staphylococcus aureus infection |
| 09/12/2013 | WO2013134146A1 Methods and compositions for treating viral infections by blocking type i interferon activity |
| 09/12/2013 | WO2013134138A1 Engineered antibody-interferon mutant fusion molecules |
| 09/12/2013 | WO2013134052A1 Il-17 antibody formulation |
| 09/12/2013 | WO2013133450A1 Pharmaceutical composition for treating cancer |
| 09/12/2013 | WO2013133405A1 Pharmaceutical composition containing peptide |
| 09/12/2013 | WO2013133297A1 Method for stimulating t cell and use thereof |
| 09/12/2013 | WO2013133253A1 Anticancer agent |
| 09/12/2013 | WO2013132526A1 Use of sphingosine-1 -phosphate receptors modulators for improving vaccine immunization |
| 09/12/2013 | WO2013132452A2 Neisseria meningitidis compositions and methods thereof |
| 09/12/2013 | WO2013132274A2 Methods of inhibiting gonad maturation |
| 09/12/2013 | WO2013132272A1 Erythropoiesis |
| 09/12/2013 | WO2013132107A1 Chimeric virus -like particles (vlp) containing functional hmpv proteins |
| 09/12/2013 | WO2013132052A1 Compositions comprising secretory - like immunoglobulins |
| 09/12/2013 | WO2013132044A1 Combination therapy of antibodies against human csf-1r and uses thereof |
| 09/12/2013 | WO2013132043A1 Combination vaccines with tlr4 agonists |
| 09/12/2013 | WO2013132041A2 Adjuvanted formulations of booster vaccines |
| 09/12/2013 | WO2013131984A1 Adjuvanted formulations of rabies virus immunogens |
| 09/12/2013 | WO2013131983A1 Adjuvanted formulations of streptococcus pneumoniae antigens |
| 09/12/2013 | WO2013131927A1 Combining dna-damaging agents and modulators of actin polymerization for the treatment of cancer |
| 09/12/2013 | WO2013131898A1 Improved vaccination against influenza |
| 09/12/2013 | WO2013131866A1 Abeta antibody formulation |
| 09/12/2013 | WO2013131565A1 Novel veterinary vaccine |
| 09/12/2013 | WO2013102042A3 Dual variable domain immunoglobulins against il-13 and/or il-17 |
| 09/12/2013 | WO2013098655A3 Vaccines directed against human enteroviruses |
| 09/12/2013 | WO2013051936A9 Adjuvant compound |
| 09/12/2013 | WO2009068992A8 Vaccination with multiple clades of h5 influenza a virus |
| 09/12/2013 | US20130239239 Lmcd1 cancer markers and methods for their use |
| 09/12/2013 | US20130237690 Stabilizing polypeptides which have been exposed to urea |
| 09/12/2013 | US20130236550 Pharmaceutical microparticles |
| 09/12/2013 | US20130236535 Antibodies |
| 09/12/2013 | US20130236533 Vaccine Nanotechnology |
| 09/12/2013 | US20130236529 Composition and methods to enhance anti-oxidation, gut flora and immunity in pets |
| 09/12/2013 | US20130236518 Materials and methods for delivering compositions to selected tissues |
| 09/12/2013 | US20130236494 Vaccination against influenza |
| 09/12/2013 | US20130236492 Adjuvanted formulations of booster vaccines |
| 09/12/2013 | US20130236491 Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes |
| 09/12/2013 | US20130236490 Multivalent Vaccine for Filariasis |
| 09/12/2013 | US20130236489 Developments in meningococcal outer membrane vesicles |
| 09/12/2013 | US20130236488 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 09/12/2013 | US20130236484 Leishmaniasis antigen detection assays and vaccines |
| 09/12/2013 | US20130236483 Fgf modulation of in vivo antibody production and humoral immunity |
| 09/12/2013 | US20130236482 Augmentation of titer for vaccination in animals |
| 09/12/2013 | US20130236481 Heterocycle -aryl compounds for inflammation and immune-related uses |
| 09/12/2013 | US20130236478 Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction |
| 09/12/2013 | US20130236477 Methods for Promoting Reinnervation of Auditory Hair Cells |
| 09/12/2013 | US20130236474 Fgf modulation of in vivo antibody production and humoral immunity |
| 09/12/2013 | US20130236473 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants |